Chiron Real Estate (XRN) Stock Forecast: StockMap's 2-Week Call
XRN stock forecast: StockMap's model leans Underperform on Chiron Real Estate for the two weeks after the Nov 19 close, toward XRN trailing the growth index. It is a lean inside the no-call band, not a call, and not a price target. Right in 2 of 5 two-week windows on XRN since Aug 26; by chance, a call on the same dates was right 63% of the time.
Chiron Real Estate last closed at $25.70, -2.02% on the session.
Against the IVW growth benchmark the position is +0.31% over the forecast window.
Chiron Real Estate's market cap is $340.45M as of November 19, 2026.
Leans down ↘: a small lean, not a call · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is -24 (too close to call).
Where XRN sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 1 bullish and 14 bearish.
Agreement across those insights is 93%.
17 daily calls for XRN so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
On the fundamentals StockMap ranks Chiron Real Estate in the 90th percentile on valuation and the 63rd percentile on return on equity, where 100 is best.
Chiron Real Estate is classified under Real Estate / Health Care REITs.
StockMap tracks Chiron Real Estate as the 17th largest of the 17 companies it covers in the Health Care REITs industry, part of the Real Estate sector.
Across that group the current two-week reads are 8 Moderate Underperform, 8 Neutral and 1 Moderate Outperform.
On that composite Chiron Real Estate ranks 12th of 17 in the group, against a group median of -0.21.